The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026.

About half of people with gout don't have treatments that work. Meet the new gout drugs racing through trials to reach them.

The only TIL therapy approved so far is Amtagvi for melanoma. Here are six companies with promising TIL therapies in the ...

We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.

The top biotech deals of July 2026 were over small molecules, cell therapies, antibodies, RNA therapeutics, vaccines, and AI.

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.

The life science sector brought about €29.7 billion ($34.41 billion) and €8.9 billion ($10.31 billion) in gross value added in 2024, according to a report by the Portuguese Trade & Investment Agency.

In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...

Radioligand therapy has been around for a long time, but 2025 was the year it started to look less like a niche tool and more like something oncology teams have to actively plan for. In March 2025, ...

You may already be familiar with protein degraders, drugs designed to eliminate disease-causing proteins, which have shown promising activity as cancer therapies. But have you heard of Regulated ...

British Columbia has become a major hub of biotech innovation within the last decade or more, and the popular coastal city of Vancouver is the center of the life sciences sector in the province. In ...

Today, Akribion Therapeutics, a German biotech company announced its €8 million ($8.2 million) seed round. Akribion Therapeutics is working on G-dase E, a programmable nuclease designed to selectively ...